Polaroid Therapeutics (PTx) Receives CE Mark for POLTX_Fiber™: the first application of APT™ to launch a new standard in wound care

ZURICH, Feb. 25, 2026 /PRNewswire/ -- Polaroid Therapeutics (PTx) today announces that POLTX_Fiber™ has received the CE Mark as a Class IIb medical device with APT™ (Antimicrobial Polymer Technology).

POLTX_Fiber™ is the company’s first product: an antimicrobial gelling fiber dressing incorporating its novel APT™. This significant moment marks Polaroid Therapeutics’ entry into the wound care sector with the goal of bringing a new standard in wound care through the APT™ platform. 

POLTX_Fiber™ is a soft, conformable non-woven dressing made of sodium carboxymethylcellulose (CMC) fibers and strengthening cellulose fibers that integrates the newly developed APT™. When the dressing is in contact with wound exudate, APT™ prevents bacterial colonization within the dressing without contributing to antimicrobial resistance. Upon absorption of exudate, the dressing forms a gel that helps maintain a moist wound environment, supports autolytic debridement, and improves the wound edge and surrounding skin from maceration.

Sign up for Blog Updates